Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

CME Now

  • What the Data Say about TXA as for Trauma

    Tranexamic acid (TXA) seems to have many uses. But where do we stand on the evidence? The...
  • In Uncomplicated AFib, Is Electrical or Chemical Rhythm Control Best?

    The Case A 52-year-old woman presents to the emergency department with sudden onset of palpitations and presyncope...
  • Droperidol Is Back (and Here’s What You Need to Know)

    In 2001, when we had agitated patients in the emergency department, we’d give them intramuscular droperidol and...

What the Data Say about TXA as for Trauma

December 20, 2019 - Ryan Patrick Radecki, MD, MS - 0 Comment

Tranexamic acid (TXA) seems to have many uses. But where do we stand on the evidence? The…

Read More

In Uncomplicated AFib, Is Electrical or Chemical Rhythm Control Best?

December 10, 2019 - Ken Milne, MD - 0 Comment

The Case A 52-year-old woman presents to the emergency department with sudden onset of palpitations and presyncope…

Read More

Droperidol Is Back (and Here’s What You Need to Know)

September 16, 2019 - Edward W. Boyer, MD, PhD - 3 Comments

In 2001, when we had agitated patients in the emergency department, we’d give them intramuscular droperidol and…

Read More

It’s Time to Abandon Fecal Occult Blood Testing in the Emergency Department

August 22, 2019 - Ryan Patrick Radecki, MD, MS - 7 Comments

If a test result does not impact management of a patient—or, worse, is misleading—should the test even…

Read More

What Emergency Physicians Need to Know About Anti-Inflammatory Monoclonal Antibodies

August 6, 2019 - W. Richard Bukata, MD - 0 Comment

If you watch network prime-time news programs at all, you can’t help but be impressed by the…

Read More

Fluoroquinolones Are in the FDA Spotlight Again

June 14, 2019 - Jeremy Samuel Faust, MD, MS; and Lauren Westafer, DO - 0 Comment

During FOAMcast, we like to cover guidelines that affect emergency physicians. But we don’t just cover the…

Read More

Factor Xa Inhibitor Reversal Agent Is Not Ready for Prime Time

May 2, 2019 - Ryan Patrick Radecki, MD, MS - 0 Comment

Ever since the release of direct-acting oral anticoagulants, emergency physicians have been tasked with managing their associated…

Read More

A Case Example: Reversing Anticoagulant Dabigatran with Idarucizumab

February 5, 2019 - W. Richard Bukata, MD - 0 Comment

The Case A 75-year-old man presents to your emergency department via paramedics. His transport time was about…

Read More

New-Drug Details: Reversing Anticoagulant Dabigatran with Idarucizumab

February 5, 2019 - Mary Choy, PharmD, BCGP, FASHP - 1 Comment

Idarucizumab (Praxbind) is the first and only specific reversal agent for a novel oral anticoagulant (NOAC) approved…

Read More

Important Information about the Seasonal Acute Flaccid Myelitis Outbreak

December 17, 2018 - David E. Hogan, DO, MPH, FACEP - 0 Comment

Nothing is more concerning to parents and emergency health care providers than a serious illness that primarily…

Read More
  • 1
  • 2
Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603